Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. In 2013, the company's largest selling product lines were Neulasta/Neupogen, two closely related drugs used to prevent infections in patients undergoing cancer chemotherapy; and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases.
Robert A. BradwayLocation
Thousand Oaks, CA, United States.
UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Amgen is implementing good security practices.
Read more about the latest issues in cybersecurity
Information security or infosec is concerned with protecting information from unauthorized access. ...
Cybersecurity risk is the probability of a cyber attack or data breach on your organization. ...
Compare Amgen's security performance with other companies